| Delivering the power of nanomedicine to patients today M Germain, F Caputo, S Metcalfe, G Tosi, K Spring, AKO Åslund, A Pottier, ... Journal of Controlled Release 326, 164-171, 2020 | 356 | 2020 |
| Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier L Costantino, F Gandolfi, G Tosi, F Rivasi, MA Vandelli, F Forni Journal of controlled release 108 (1), 84-96, 2005 | 290 | 2005 |
| Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 G Tosi, L Costantino, F Rivasi, B Ruozi, E Leo, AV Vergoni, R Tacchi, ... Journal of controlled release 122 (1), 1-9, 2007 | 285 | 2007 |
| Polymeric nanoparticles for the drug delivery to the central nervous system G Tosi, L Costantino, B Ruozi, F Forni, MA Vandelli Expert opinion on drug delivery 5 (2), 155-174, 2008 | 282 | 2008 |
| AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study B Ruozi, D Belletti, A Tombesi, G Tosi, L Bondioli, F Forni, MA Vandelli International journal of nanomedicine, 557-563, 2011 | 267 | 2011 |
| Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges MM Wen, NS El-Salamouni, WM El-Refaie, HA Hazzah, MM Ali, G Tosi, ... Journal of controlled release 245, 95-107, 2017 | 219 | 2017 |
| Nanoparticle transport across the blood brain barrier AM Grabrucker, B Ruozi, D Belletti, F Pederzoli, F Forni, MA Vandelli, ... Tissue barriers 4 (1), e1153568, 2016 | 212 | 2016 |
| Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution AV Vergoni, G Tosi, R Tacchi, MA Vandelli, A Bertolini, L Costantino Nanomedicine: Nanotechnology, Biology and Medicine 5 (4), 369-377, 2009 | 198 | 2009 |
| Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates R Barbara, D Belletti, F Pederzoli, M Masoni, J Keller, A Ballestrazzi, ... International journal of pharmaceutics 526 (1-2), 413-424, 2017 | 180 | 2017 |
| Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes B Ruozi, G Tosi, F Forni, M Fresta, MA Vandelli European Journal of Pharmaceutical Sciences 25 (1), 81-89, 2005 | 172 | 2005 |
| Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier G Tosi, B Bortot, B Ruozi, D Dolcetta, MA Vandelli, F Forni, GM Severini Current medicinal chemistry 20 (17), 2212-2225, 2013 | 169 | 2013 |
| Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: in vivo pharmacological evidence and biodistribution G Tosi, AV Vergoni, B Ruozi, L Bondioli, L Badiali, F Rivasi, L Costantino, ... Journal of controlled release 145 (1), 49-57, 2010 | 160 | 2010 |
| Protein corona and nanoparticles: how can we investigate on? F Pederzoli, G Tosi, MA Vandelli, D Belletti, F Forni, B Ruozi Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (6), e1467, 2017 | 148 | 2017 |
| Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers JJE Mulvihill, EM Cunnane, AM Ross, JT Duskey, G Tosi, AM Grabrucker Nanomedicine 15 (2), 205-214, 2020 | 142 | 2020 |
| Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier G Tosi, JT Duskey, J Kreuter Expert opinion on drug delivery 17 (1), 23-32, 2020 | 123 | 2020 |
| Application of atomic force microscopy to characterize liposomes as drug and gene carriers B Ruozi, G Tosi, E Leo, MA Vandelli Talanta 73 (1), 12-22, 2007 | 115 | 2007 |
| Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood–brain barrier G Tosi, RA Fano, L Bondioli, L Badiali, R Benassi, F Rivasi, B Ruozi, ... Nanomedicine 6 (3), 423-436, 2011 | 110 | 2011 |
| Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders M Salvalaio, L Rigon, D Belletti, F D’Avanzo, F Pederzoli, B Ruozi, ... PloS one 11 (5), e0156452, 2016 | 108 | 2016 |
| Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution A Vilella, G Tosi, AM Grabrucker, B Ruozi, D Belletti, MA Vandelli, ... Journal of Controlled Release 174, 195-201, 2014 | 107 | 2014 |
| Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in H untington's disease mice M Valenza, JY Chen, E Di Paolo, B Ruozi, D Belletti, C Ferrari Bardile, ... EMBO molecular medicine 7 (12), 1547-1564, 2015 | 104 | 2015 |
